会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • SPINAL ORTHOSES
    • 脊柱畸形
    • US20090054818A1
    • 2009-02-26
    • US11628996
    • 2005-06-09
    • Kenton R. KaufmanMichael J. Yaszemski
    • Kenton R. KaufmanMichael J. Yaszemski
    • A61F5/00
    • A61F5/34A61F5/012A61F5/022A61F5/024
    • A thoracolumbosacral and a lumbosacral orthosis with sagittal-coronal control are disclosed. The orthoses have two rigid anterior and posterior plastic shells. The anterior shell extends from the pelvis to the sternum. The posterior shell extends from the pelvis and terminates just inferior to the scapular spine. An interior surface of the anterior shell has pressure pads that apply pressure to locations on the patient's anterior torso and the interior surface of the posterior shell has pressure pads that apply pressure to locations on the patient's posterior torso when the anterior shell and the posterior shell are secured to the patient's torso. The pressure pads may be inflatable air bladders.
    • 公开了一种具有矢状冠状动脉控制的胸腰椎和腰骶矫形器。 矫形器有两个刚性的前后塑料外壳。 前囊从骨盆延伸到胸骨。 后壳从骨盆延伸,终止于肩胛骨下方。 前壳的内表面具有对患者前躯干上的位置施加压力的压力垫,并且后壳的内表面具有压力垫,当前壳和后壳是前壳和后壳时,压力垫对患者的后躯体上的位置施加压力 固定在患者的躯干上。 压垫可以是可充气的气囊。
    • 18. 发明授权
    • Spinal cord surgical implant
    • 脊髓手术植入物
    • US07163545B2
    • 2007-01-16
    • US10629427
    • 2003-07-29
    • Michael J. YaszemskiJonathan A. FriedmanMichael J. MooreAnthony J. Windebank
    • Michael J. YaszemskiJonathan A. FriedmanMichael J. MooreAnthony J. Windebank
    • A61B17/08
    • A61B17/08A61B17/1128A61L27/383A61L27/3878A61L27/58A61L31/005A61L31/148A61L2430/32
    • An implant for bridging a gap in a severed spinal cord or nerve and for promoting nerve regeneration has a matrix comprising a biocompatible, biodegradable, polymeric material. The matrix has a proximal end for connection to a first end of severed spinal cord and a distal end for connection to a second end of severed spinal cord. The matrix includes internal guidance channels extending between the proximal end and the distal end to facilitate rejoining of the first end and the second end of the severed spinal cord. A bioactive agent may be dispersed in the matrix, or disposed in the channels, or included within microspheres in the channels. The channels may be arranged such that guidance channels correspond to spinal cord tracts. Alternatively, guidance channels may be spaced apart at the proximal end of the matrix and converge inward toward the axis of the matrix at the distal end.
    • 用于桥接切断的脊髓或神经中的间隙并用于促进神经再生的植入物具有包含生物相容性,可生物降解的聚合材料的基质。 基质具有用于连接到切断的脊髓的第一端的近端和用于连接到切断的脊髓的第二端的远端。 基体包括在近端和远端之间延伸的内部引导通道,以便于重新连接切断的脊髓的第一端和第二端。 生物活性剂可以分散在基质中,或者设置在通道中,或者包含在通道中的微球体内。 通道可以布置成使得引导通道对应于脊髓束。 或者,引导通道可以在基体的近端处间隔开并且在远端处朝向矩阵的轴线向内收敛。
    • 19. 发明申请
    • Conductive polymeric composites of polycaprolactone fumarate and polypyrrole for nerve regeneration
    • 富马酸聚己内酯和聚吡咯的导电聚合物复合材料用于神经再生
    • US20130331869A1
    • 2013-12-12
    • US12925182
    • 2010-10-15
    • M. Brett RungeMahrokh DadsetanMichael J. Yaszemski
    • M. Brett RungeMahrokh DadsetanMichael J. Yaszemski
    • A61F2/04A61N1/05
    • A61F2/04A61L27/26A61L27/383A61L27/3834A61L27/54A61L2430/32A61N1/0551A61N1/326A61N1/36103C08L67/04C08L65/00
    • A novel electrically conductive polymer composite composed of polycaprolactone fumarate-polypyrrole (PCLF-PPy) for applications in nerve regeneration is disclosed. The synthesis and characterization of PCLF-PPy and in vitro studies showing PCLF-PPy supports both PC12 cell and Dorsal Root Ganglia neurite extension. PCLF-PPy composite materials were synthesized by polymerizing pyrrole in pre-formed scaffolds of PCLF resulting in an interpenetrating network of PCLF-PPy. PCLF-PPy composite materials possess electrical conductivity up to 6 mS cm−1 with compositions ranging from 5-13.5 percent polypyrrole of the bulk material. Surface topographies of PCLF-PPy materials show microstructures with a RMS roughness of 1195 nm and nanostructures with RMS roughness of 8 nm. PCLF-PPy derivatives were synthesized with anionic dopants to determine effects on electrical conductivity and to optimize the chemical composition for biocompatibility. In vitro studies using PC12 show PCLF-PPy composite materials induce a higher cellular viability and increased neurite extension compared to PCLF. PCLF-PPy composites doped with either naphthalene sulfonic acid or dodecyl benzene sulfonic acid are determined to be the optimal materials for electrical stimulation. In vitro studies showed significant increases in percentage of neurite bearing cells, number of neurites per cell and neurite length in the presence of ES compared to no ES. Additionally, extending neurites were observed to align in the direction of the applied current. Electrically conductive PCLF-PPy scaffolds possess material properties necessary for application as nerve conduits. Additionally, the capability to significantly enhance and direct neurite extension by passing electrical current through PCLF-PPy scaffolds renders them even more promising as future therapeutic treatments for severe nerve injuries.
    • 公开了一种用于神经再生的聚己内酯富马酸酯 - 聚吡咯(PCLF-PPy)的新型导电聚合物复合材料。 PCLF-PPy的合成和表征和体外研究显示PCLF-PPy支持PC12细胞和背根神经节神经突延伸。 PCLF-PPy复合材料通过在PCLF的预形成支架中聚合吡咯合成,得到PCLF-PPy的互穿网络。 PCLF-PPy复合材料具有高达6 mS cm-1的电导率,组成范围为散装材料的5-13.5%聚吡咯。 PCLF-PPy材料的表面形貌显示RMS粗糙度为1195 nm的微结构,RMS粗糙度为8 nm的纳米结构。 用阴离子掺杂剂合成PCLF-PPy衍生物,以确定对电导率的影响,并优化生物相容性的化学成分。 使用PC12的体外研究显示,与PCLF相比,PCLF-PPy复合材料诱导更高的细胞活力和增加的神经突延伸。 掺入萘磺酸或十二烷基苯磺酸的PCLF-PPy复合材料被确定为电刺激的最佳材料。 与没有ES相比,体外研究显示,在存在ES的情况下,轴突细胞的轴突细胞百分比,每个细胞的神经突数和神经突长度的显着增加。 另外,观察到延伸的神经突沿所施加电流的方向排列。 导电PCLF-PPy支架具有作为神经导管应用所需的材料特性。 此外,通过使电流通过PCLF-PPy支架,显着增强和引导神经突延伸的能力使得它们作为未来治疗严重神经损伤的治疗方法更有希望。